nodes	percent_of_prediction	percent_of_DWPC	metapath
Albendazole—ABCB1—epilepsy syndrome	0.155	1	CbGaD
Albendazole—CYP1A1—Propofol—epilepsy syndrome	0.0414	0.0738	CbGbCtD
Albendazole—CYP1A1—Phenobarbital—epilepsy syndrome	0.0396	0.0705	CbGbCtD
Albendazole—ABCB1—Levetiracetam—epilepsy syndrome	0.0337	0.06	CbGbCtD
Albendazole—ABCB1—Clobazam—epilepsy syndrome	0.0233	0.0416	CbGbCtD
Albendazole—ABCB1—Lamotrigine—epilepsy syndrome	0.0225	0.04	CbGbCtD
Albendazole—CYP1A2—Carbamazepine—epilepsy syndrome	0.0221	0.0394	CbGbCtD
Albendazole—CYP1A2—Primidone—epilepsy syndrome	0.0206	0.0368	CbGbCtD
Albendazole—ABCB1—Carbamazepine—epilepsy syndrome	0.0193	0.0344	CbGbCtD
Albendazole—CYP1A2—Propofol—epilepsy syndrome	0.0185	0.0329	CbGbCtD
Albendazole—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0184	0.0329	CbGbCtD
Albendazole—CYP1A2—Phenobarbital—epilepsy syndrome	0.0177	0.0315	CbGbCtD
Albendazole—ABCB1—Phenytoin—epilepsy syndrome	0.0173	0.0309	CbGbCtD
Albendazole—CYP3A4—Felbamate—epilepsy syndrome	0.0171	0.0306	CbGbCtD
Albendazole—CYP3A4—Trimethadione—epilepsy syndrome	0.0171	0.0306	CbGbCtD
Albendazole—CYP1A2—Diazepam—epilepsy syndrome	0.0168	0.0299	CbGbCtD
Albendazole—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0161	0.0287	CbGbCtD
Albendazole—ABCB1—Phenobarbital—epilepsy syndrome	0.0155	0.0275	CbGbCtD
Albendazole—ABCB1—Midazolam—epilepsy syndrome	0.0152	0.0272	CbGbCtD
Albendazole—ABCB1—Diazepam—epilepsy syndrome	0.0146	0.0261	CbGbCtD
Albendazole—CYP3A4—Clonazepam—epilepsy syndrome	0.0146	0.026	CbGbCtD
Albendazole—CYP3A4—Clobazam—epilepsy syndrome	0.014	0.0249	CbGbCtD
Albendazole—CYP1A2—Valproic Acid—epilepsy syndrome	0.0132	0.0235	CbGbCtD
Albendazole—CYP3A4—Rufinamide—epilepsy syndrome	0.0119	0.0212	CbGbCtD
Albendazole—CYP3A4—Carbamazepine—epilepsy syndrome	0.0116	0.0206	CbGbCtD
Albendazole—CYP3A4—Primidone—epilepsy syndrome	0.0108	0.0193	CbGbCtD
Albendazole—CYP3A4—Phenytoin—epilepsy syndrome	0.0104	0.0185	CbGbCtD
Albendazole—CYP3A4—Propofol—epilepsy syndrome	0.00969	0.0173	CbGbCtD
Albendazole—CYP3A4—Acetazolamide—epilepsy syndrome	0.00926	0.0165	CbGbCtD
Albendazole—CYP3A4—Phenobarbital—epilepsy syndrome	0.00926	0.0165	CbGbCtD
Albendazole—CYP3A4—Midazolam—epilepsy syndrome	0.00913	0.0163	CbGbCtD
Albendazole—CYP3A4—Diazepam—epilepsy syndrome	0.00878	0.0156	CbGbCtD
Albendazole—CYP3A4—Zonisamide—epilepsy syndrome	0.00857	0.0153	CbGbCtD
Albendazole—TUBA1A—pons—epilepsy syndrome	0.0082	0.202	CbGeAlD
Albendazole—CYP3A4—Valproic Acid—epilepsy syndrome	0.00692	0.0123	CbGbCtD
Albendazole—CYP3A4—Topiramate—epilepsy syndrome	0.00624	0.0111	CbGbCtD
Albendazole—TUBA1A—ganglion—epilepsy syndrome	0.0042	0.103	CbGeAlD
Albendazole—TUBA1A—hindbrain—epilepsy syndrome	0.00319	0.0784	CbGeAlD
Albendazole—TUBA1A—brainstem—epilepsy syndrome	0.00183	0.045	CbGeAlD
Albendazole—TUBB4B—Niclosamide—Clonazepam—epilepsy syndrome	0.00176	1	CbGdCrCtD
Albendazole—TUBA1A—forebrain—epilepsy syndrome	0.00176	0.0434	CbGeAlD
Albendazole—TUBA1A—telencephalon—epilepsy syndrome	0.00162	0.0399	CbGeAlD
Albendazole—TUBA1A—medulla oblongata—epilepsy syndrome	0.00127	0.0313	CbGeAlD
Albendazole—TUBB4B—forebrain—epilepsy syndrome	0.00117	0.0289	CbGeAlD
Albendazole—TUBA1A—midbrain—epilepsy syndrome	0.00116	0.0286	CbGeAlD
Albendazole—TUBA1A—spinal cord—epilepsy syndrome	0.00114	0.028	CbGeAlD
Albendazole—TUBB4B—telencephalon—epilepsy syndrome	0.00108	0.0266	CbGeAlD
Albendazole—TUBA1A—head—epilepsy syndrome	0.00101	0.0248	CbGeAlD
Albendazole—TUBA1A—nervous system—epilepsy syndrome	0.000957	0.0236	CbGeAlD
Albendazole—TUBA1A—central nervous system—epilepsy syndrome	0.000921	0.0227	CbGeAlD
Albendazole—TUBA1A—cerebellum—epilepsy syndrome	0.0009	0.0222	CbGeAlD
Albendazole—TUBB4B—medulla oblongata—epilepsy syndrome	0.000849	0.0209	CbGeAlD
Albendazole—TUBB4B—midbrain—epilepsy syndrome	0.000776	0.0191	CbGeAlD
Albendazole—TUBB4B—spinal cord—epilepsy syndrome	0.000757	0.0186	CbGeAlD
Albendazole—TUBA1A—brain—epilepsy syndrome	0.000731	0.018	CbGeAlD
Albendazole—TUBB4B—head—epilepsy syndrome	0.000673	0.0166	CbGeAlD
Albendazole—TUBB4B—nervous system—epilepsy syndrome	0.000638	0.0157	CbGeAlD
Albendazole—TUBB4B—central nervous system—epilepsy syndrome	0.000614	0.0151	CbGeAlD
Albendazole—TUBB4B—cerebellum—epilepsy syndrome	0.0006	0.0148	CbGeAlD
Albendazole—TUBB4B—brain—epilepsy syndrome	0.000487	0.012	CbGeAlD
Albendazole—CYP1A1—head—epilepsy syndrome	0.000377	0.00927	CbGeAlD
Albendazole—CYP1A1—nervous system—epilepsy syndrome	0.000357	0.00879	CbGeAlD
Albendazole—CYP1A1—central nervous system—epilepsy syndrome	0.000344	0.00846	CbGeAlD
Albendazole—ABCB1—forebrain—epilepsy syndrome	0.000342	0.00841	CbGeAlD
Albendazole—ABCB1—telencephalon—epilepsy syndrome	0.000314	0.00773	CbGeAlD
Albendazole—Leukopenia—Lamotrigine—epilepsy syndrome	0.000305	0.00173	CcSEcCtD
Albendazole—Urethral disorder—Valproic Acid—epilepsy syndrome	0.000305	0.00173	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Carbamazepine—epilepsy syndrome	0.000299	0.00169	CcSEcCtD
Albendazole—Nausea—Phenobarbital—epilepsy syndrome	0.000298	0.00169	CcSEcCtD
Albendazole—Thrombocytopenia—Clonazepam—epilepsy syndrome	0.000298	0.00169	CcSEcCtD
Albendazole—Dizziness—Clobazam—epilepsy syndrome	0.000297	0.00168	CcSEcCtD
Albendazole—Thrombocytopenia—Phenytoin—epilepsy syndrome	0.000296	0.00168	CcSEcCtD
Albendazole—Urticaria—Propofol—epilepsy syndrome	0.000295	0.00168	CcSEcCtD
Albendazole—Skin disorder—Clonazepam—epilepsy syndrome	0.000295	0.00167	CcSEcCtD
Albendazole—Erythema multiforme—Valproic Acid—epilepsy syndrome	0.000295	0.00167	CcSEcCtD
Albendazole—Vomiting—Lacosamide—epilepsy syndrome	0.000294	0.00167	CcSEcCtD
Albendazole—Body temperature increased—Propofol—epilepsy syndrome	0.000294	0.00167	CcSEcCtD
Albendazole—Abdominal pain—Propofol—epilepsy syndrome	0.000294	0.00167	CcSEcCtD
Albendazole—Thrombocytopenia—Oxcarbazepine—epilepsy syndrome	0.000294	0.00167	CcSEcCtD
Albendazole—Gastrointestinal pain—Levetiracetam—epilepsy syndrome	0.000294	0.00167	CcSEcCtD
Albendazole—Nausea—Rufinamide—epilepsy syndrome	0.000293	0.00166	CcSEcCtD
Albendazole—Rash—Lacosamide—epilepsy syndrome	0.000292	0.00166	CcSEcCtD
Albendazole—Skin disorder—Oxcarbazepine—epilepsy syndrome	0.000292	0.00165	CcSEcCtD
Albendazole—Dermatitis—Lacosamide—epilepsy syndrome	0.000292	0.00165	CcSEcCtD
Albendazole—Headache—Lacosamide—epilepsy syndrome	0.00029	0.00164	CcSEcCtD
Albendazole—Liver function test abnormal—Topiramate—epilepsy syndrome	0.00029	0.00164	CcSEcCtD
Albendazole—Urticaria—Midazolam—epilepsy syndrome	0.000289	0.00164	CcSEcCtD
Albendazole—Vomiting—Clobazam—epilepsy syndrome	0.000286	0.00162	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Gabapentin—epilepsy syndrome	0.000285	0.00162	CcSEcCtD
Albendazole—Body temperature increased—Levetiracetam—epilepsy syndrome	0.000284	0.00161	CcSEcCtD
Albendazole—Abdominal pain—Levetiracetam—epilepsy syndrome	0.000284	0.00161	CcSEcCtD
Albendazole—Rash—Clobazam—epilepsy syndrome	0.000283	0.00161	CcSEcCtD
Albendazole—Dermatitis—Clobazam—epilepsy syndrome	0.000283	0.0016	CcSEcCtD
Albendazole—Thrombocytopenia—Carbamazepine—epilepsy syndrome	0.000282	0.0016	CcSEcCtD
Albendazole—Hepatitis—Pregabalin—epilepsy syndrome	0.000282	0.0016	CcSEcCtD
Albendazole—Headache—Clobazam—epilepsy syndrome	0.000281	0.0016	CcSEcCtD
Albendazole—Immune system disorder—Valproic Acid—epilepsy syndrome	0.000281	0.0016	CcSEcCtD
Albendazole—Skin disorder—Carbamazepine—epilepsy syndrome	0.00028	0.00159	CcSEcCtD
Albendazole—Urinary tract disorder—Pregabalin—epilepsy syndrome	0.000278	0.00158	CcSEcCtD
Albendazole—Gastrointestinal pain—Vigabatrin—epilepsy syndrome	0.000276	0.00157	CcSEcCtD
Albendazole—Urethral disorder—Pregabalin—epilepsy syndrome	0.000276	0.00157	CcSEcCtD
Albendazole—Urticaria—Fosphenytoin—epilepsy syndrome	0.000276	0.00156	CcSEcCtD
Albendazole—Alopecia—Valproic Acid—epilepsy syndrome	0.000275	0.00156	CcSEcCtD
Albendazole—Nausea—Lacosamide—epilepsy syndrome	0.000275	0.00156	CcSEcCtD
Albendazole—Body temperature increased—Fosphenytoin—epilepsy syndrome	0.000274	0.00155	CcSEcCtD
Albendazole—CYP1A1—brain—epilepsy syndrome	0.000273	0.00672	CbGeAlD
Albendazole—Thrombocytopenia—Lamotrigine—epilepsy syndrome	0.000273	0.00155	CcSEcCtD
Albendazole—Gastrointestinal pain—Diazepam—epilepsy syndrome	0.000272	0.00154	CcSEcCtD
Albendazole—Hepatobiliary disease—Gabapentin—epilepsy syndrome	0.000272	0.00154	CcSEcCtD
Albendazole—Urticaria—Vigabatrin—epilepsy syndrome	0.000269	0.00152	CcSEcCtD
Albendazole—Hypersensitivity—Midazolam—epilepsy syndrome	0.000268	0.00152	CcSEcCtD
Albendazole—Body temperature increased—Vigabatrin—epilepsy syndrome	0.000267	0.00152	CcSEcCtD
Albendazole—Abdominal pain—Vigabatrin—epilepsy syndrome	0.000267	0.00152	CcSEcCtD
Albendazole—Nausea—Clobazam—epilepsy syndrome	0.000267	0.00151	CcSEcCtD
Albendazole—Erythema multiforme—Pregabalin—epilepsy syndrome	0.000266	0.00151	CcSEcCtD
Albendazole—Dizziness—Acetazolamide—epilepsy syndrome	0.000265	0.0015	CcSEcCtD
Albendazole—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000265	0.0015	CcSEcCtD
Albendazole—Urticaria—Diazepam—epilepsy syndrome	0.000264	0.0015	CcSEcCtD
Albendazole—Gastrointestinal pain—Felbamate—epilepsy syndrome	0.000263	0.00149	CcSEcCtD
Albendazole—Abdominal pain—Diazepam—epilepsy syndrome	0.000263	0.00149	CcSEcCtD
Albendazole—CYP3A4—nervous system—epilepsy syndrome	0.000262	0.00645	CbGeAlD
Albendazole—Hepatitis—Gabapentin—epilepsy syndrome	0.000258	0.00146	CcSEcCtD
Albendazole—Gastrointestinal pain—Zonisamide—epilepsy syndrome	0.000258	0.00146	CcSEcCtD
Albendazole—Pancytopenia—Topiramate—epilepsy syndrome	0.000258	0.00146	CcSEcCtD
Albendazole—Urticaria—Felbamate—epilepsy syndrome	0.000256	0.00145	CcSEcCtD
Albendazole—Urinary tract disorder—Gabapentin—epilepsy syndrome	0.000255	0.00145	CcSEcCtD
Albendazole—Body temperature increased—Felbamate—epilepsy syndrome	0.000255	0.00144	CcSEcCtD
Albendazole—Abdominal pain—Felbamate—epilepsy syndrome	0.000255	0.00144	CcSEcCtD
Albendazole—Vomiting—Acetazolamide—epilepsy syndrome	0.000255	0.00144	CcSEcCtD
Albendazole—Immune system disorder—Pregabalin—epilepsy syndrome	0.000254	0.00144	CcSEcCtD
Albendazole—Neutropenia—Topiramate—epilepsy syndrome	0.000254	0.00144	CcSEcCtD
Albendazole—Urethral disorder—Gabapentin—epilepsy syndrome	0.000253	0.00144	CcSEcCtD
Albendazole—CYP3A4—central nervous system—epilepsy syndrome	0.000252	0.00621	CbGeAlD
Albendazole—Headache—Acetazolamide—epilepsy syndrome	0.000251	0.00142	CcSEcCtD
Albendazole—Urticaria—Zonisamide—epilepsy syndrome	0.000251	0.00142	CcSEcCtD
Albendazole—Abdominal pain—Zonisamide—epilepsy syndrome	0.000249	0.00141	CcSEcCtD
Albendazole—Body temperature increased—Zonisamide—epilepsy syndrome	0.000249	0.00141	CcSEcCtD
Albendazole—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000249	0.00141	CcSEcCtD
Albendazole—Alopecia—Pregabalin—epilepsy syndrome	0.000249	0.00141	CcSEcCtD
Albendazole—Gastrointestinal pain—Clonazepam—epilepsy syndrome	0.000249	0.00141	CcSEcCtD
Albendazole—ABCB1—medulla oblongata—epilepsy syndrome	0.000247	0.00608	CbGeAlD
Albendazole—Dizziness—Propofol—epilepsy syndrome	0.000246	0.00139	CcSEcCtD
Albendazole—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	0.000246	0.00139	CcSEcCtD
Albendazole—Hypersensitivity—Diazepam—epilepsy syndrome	0.000245	0.00139	CcSEcCtD
Albendazole—Erythema multiforme—Gabapentin—epilepsy syndrome	0.000244	0.00138	CcSEcCtD
Albendazole—Vertigo—Valproic Acid—epilepsy syndrome	0.000244	0.00138	CcSEcCtD
Albendazole—Leukopenia—Valproic Acid—epilepsy syndrome	0.000243	0.00138	CcSEcCtD
Albendazole—Urticaria—Clonazepam—epilepsy syndrome	0.000241	0.00137	CcSEcCtD
Albendazole—Dizziness—Midazolam—epilepsy syndrome	0.000241	0.00136	CcSEcCtD
Albendazole—Body temperature increased—Clonazepam—epilepsy syndrome	0.00024	0.00136	CcSEcCtD
Albendazole—Abdominal pain—Clonazepam—epilepsy syndrome	0.00024	0.00136	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Topiramate—epilepsy syndrome	0.00024	0.00136	CcSEcCtD
Albendazole—Urticaria—Phenytoin—epilepsy syndrome	0.00024	0.00136	CcSEcCtD
Albendazole—Body temperature increased—Phenytoin—epilepsy syndrome	0.000239	0.00135	CcSEcCtD
Albendazole—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000239	0.00135	CcSEcCtD
Albendazole—Nausea—Acetazolamide—epilepsy syndrome	0.000238	0.00135	CcSEcCtD
Albendazole—Dizziness—Levetiracetam—epilepsy syndrome	0.000238	0.00135	CcSEcCtD
Albendazole—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.000237	0.00135	CcSEcCtD
Albendazole—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000237	0.00135	CcSEcCtD
Albendazole—Vomiting—Propofol—epilepsy syndrome	0.000237	0.00134	CcSEcCtD
Albendazole—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.000236	0.00134	CcSEcCtD
Albendazole—Rash—Propofol—epilepsy syndrome	0.000235	0.00133	CcSEcCtD
Albendazole—Dermatitis—Propofol—epilepsy syndrome	0.000234	0.00133	CcSEcCtD
Albendazole—Immune system disorder—Gabapentin—epilepsy syndrome	0.000233	0.00132	CcSEcCtD
Albendazole—Headache—Propofol—epilepsy syndrome	0.000233	0.00132	CcSEcCtD
Albendazole—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000232	0.00132	CcSEcCtD
Albendazole—Vomiting—Midazolam—epilepsy syndrome	0.000231	0.00131	CcSEcCtD
Albendazole—Rash—Midazolam—epilepsy syndrome	0.000229	0.0013	CcSEcCtD
Albendazole—Dizziness—Fosphenytoin—epilepsy syndrome	0.000229	0.0013	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	0.000229	0.0013	CcSEcCtD
Albendazole—Dermatitis—Midazolam—epilepsy syndrome	0.000229	0.0013	CcSEcCtD
Albendazole—Urticaria—Carbamazepine—epilepsy syndrome	0.000229	0.0013	CcSEcCtD
Albendazole—Vomiting—Levetiracetam—epilepsy syndrome	0.000228	0.0013	CcSEcCtD
Albendazole—Alopecia—Gabapentin—epilepsy syndrome	0.000228	0.00129	CcSEcCtD
Albendazole—Headache—Midazolam—epilepsy syndrome	0.000228	0.00129	CcSEcCtD
Albendazole—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000228	0.00129	CcSEcCtD
Albendazole—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000228	0.00129	CcSEcCtD
Albendazole—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000228	0.00129	CcSEcCtD
Albendazole—Rash—Levetiracetam—epilepsy syndrome	0.000227	0.00128	CcSEcCtD
Albendazole—Dermatitis—Levetiracetam—epilepsy syndrome	0.000226	0.00128	CcSEcCtD
Albendazole—Agranulocytosis—Topiramate—epilepsy syndrome	0.000226	0.00128	CcSEcCtD
Albendazole—ABCB1—midbrain—epilepsy syndrome	0.000226	0.00555	CbGeAlD
Albendazole—Headache—Levetiracetam—epilepsy syndrome	0.000225	0.00128	CcSEcCtD
Albendazole—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000224	0.00127	CcSEcCtD
Albendazole—Dizziness—Vigabatrin—epilepsy syndrome	0.000224	0.00127	CcSEcCtD
Albendazole—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000222	0.00126	CcSEcCtD
Albendazole—Urticaria—Lamotrigine—epilepsy syndrome	0.000221	0.00125	CcSEcCtD
Albendazole—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000221	0.00125	CcSEcCtD
Albendazole—Nausea—Propofol—epilepsy syndrome	0.000221	0.00125	CcSEcCtD
Albendazole—Vomiting—Fosphenytoin—epilepsy syndrome	0.000221	0.00125	CcSEcCtD
Albendazole—Vertigo—Pregabalin—epilepsy syndrome	0.00022	0.00125	CcSEcCtD
Albendazole—Abdominal pain—Lamotrigine—epilepsy syndrome	0.00022	0.00125	CcSEcCtD
Albendazole—Body temperature increased—Lamotrigine—epilepsy syndrome	0.00022	0.00125	CcSEcCtD
Albendazole—Dizziness—Diazepam—epilepsy syndrome	0.00022	0.00125	CcSEcCtD
Albendazole—ABCB1—spinal cord—epilepsy syndrome	0.00022	0.00542	CbGeAlD
Albendazole—Leukopenia—Pregabalin—epilepsy syndrome	0.000219	0.00124	CcSEcCtD
Albendazole—Rash—Fosphenytoin—epilepsy syndrome	0.000219	0.00124	CcSEcCtD
Albendazole—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000218	0.00124	CcSEcCtD
Albendazole—Headache—Fosphenytoin—epilepsy syndrome	0.000217	0.00123	CcSEcCtD
Albendazole—Hepatitis—Topiramate—epilepsy syndrome	0.000217	0.00123	CcSEcCtD
Albendazole—Thrombocytopenia—Valproic Acid—epilepsy syndrome	0.000217	0.00123	CcSEcCtD
Albendazole—Nausea—Midazolam—epilepsy syndrome	0.000216	0.00123	CcSEcCtD
Albendazole—Vomiting—Vigabatrin—epilepsy syndrome	0.000215	0.00122	CcSEcCtD
Albendazole—Skin disorder—Valproic Acid—epilepsy syndrome	0.000215	0.00122	CcSEcCtD
Albendazole—Urinary tract disorder—Topiramate—epilepsy syndrome	0.000215	0.00122	CcSEcCtD
Albendazole—Nausea—Levetiracetam—epilepsy syndrome	0.000213	0.00121	CcSEcCtD
Albendazole—Rash—Vigabatrin—epilepsy syndrome	0.000213	0.00121	CcSEcCtD
Albendazole—Dizziness—Felbamate—epilepsy syndrome	0.000213	0.00121	CcSEcCtD
Albendazole—Dermatitis—Vigabatrin—epilepsy syndrome	0.000213	0.00121	CcSEcCtD
Albendazole—Urethral disorder—Topiramate—epilepsy syndrome	0.000213	0.00121	CcSEcCtD
Albendazole—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000212	0.0012	CcSEcCtD
Albendazole—Headache—Vigabatrin—epilepsy syndrome	0.000212	0.0012	CcSEcCtD
Albendazole—Vomiting—Diazepam—epilepsy syndrome	0.000212	0.0012	CcSEcCtD
Albendazole—Rash—Diazepam—epilepsy syndrome	0.00021	0.00119	CcSEcCtD
Albendazole—Dermatitis—Diazepam—epilepsy syndrome	0.00021	0.00119	CcSEcCtD
Albendazole—Dizziness—Zonisamide—epilepsy syndrome	0.000209	0.00118	CcSEcCtD
Albendazole—Headache—Diazepam—epilepsy syndrome	0.000209	0.00118	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000207	0.00118	CcSEcCtD
Albendazole—Nausea—Fosphenytoin—epilepsy syndrome	0.000206	0.00117	CcSEcCtD
Albendazole—Erythema multiforme—Topiramate—epilepsy syndrome	0.000205	0.00116	CcSEcCtD
Albendazole—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000205	0.00116	CcSEcCtD
Albendazole—Vomiting—Felbamate—epilepsy syndrome	0.000205	0.00116	CcSEcCtD
Albendazole—Rash—Felbamate—epilepsy syndrome	0.000203	0.00115	CcSEcCtD
Albendazole—Dermatitis—Felbamate—epilepsy syndrome	0.000203	0.00115	CcSEcCtD
Albendazole—Vertigo—Gabapentin—epilepsy syndrome	0.000202	0.00115	CcSEcCtD
Albendazole—Headache—Felbamate—epilepsy syndrome	0.000202	0.00114	CcSEcCtD
Albendazole—Leukopenia—Gabapentin—epilepsy syndrome	0.000201	0.00114	CcSEcCtD
Albendazole—Dizziness—Clonazepam—epilepsy syndrome	0.000201	0.00114	CcSEcCtD
Albendazole—Nausea—Vigabatrin—epilepsy syndrome	0.000201	0.00114	CcSEcCtD
Albendazole—Vomiting—Zonisamide—epilepsy syndrome	0.0002	0.00114	CcSEcCtD
Albendazole—Dizziness—Phenytoin—epilepsy syndrome	0.0002	0.00113	CcSEcCtD
Albendazole—Rash—Zonisamide—epilepsy syndrome	0.000199	0.00113	CcSEcCtD
Albendazole—Dermatitis—Zonisamide—epilepsy syndrome	0.000199	0.00113	CcSEcCtD
Albendazole—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000199	0.00113	CcSEcCtD
Albendazole—Nausea—Diazepam—epilepsy syndrome	0.000198	0.00112	CcSEcCtD
Albendazole—Headache—Zonisamide—epilepsy syndrome	0.000198	0.00112	CcSEcCtD
Albendazole—Immune system disorder—Topiramate—epilepsy syndrome	0.000196	0.00111	CcSEcCtD
Albendazole—Thrombocytopenia—Pregabalin—epilepsy syndrome	0.000196	0.00111	CcSEcCtD
Albendazole—ABCB1—head—epilepsy syndrome	0.000196	0.00482	CbGeAlD
Albendazole—Skin disorder—Pregabalin—epilepsy syndrome	0.000194	0.0011	CcSEcCtD
Albendazole—Vomiting—Clonazepam—epilepsy syndrome	0.000193	0.0011	CcSEcCtD
Albendazole—Alopecia—Topiramate—epilepsy syndrome	0.000192	0.00109	CcSEcCtD
Albendazole—Vomiting—Phenytoin—epilepsy syndrome	0.000192	0.00109	CcSEcCtD
Albendazole—Rash—Clonazepam—epilepsy syndrome	0.000192	0.00109	CcSEcCtD
Albendazole—Dermatitis—Clonazepam—epilepsy syndrome	0.000191	0.00109	CcSEcCtD
Albendazole—Nausea—Felbamate—epilepsy syndrome	0.000191	0.00108	CcSEcCtD
Albendazole—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000191	0.00108	CcSEcCtD
Albendazole—Dizziness—Carbamazepine—epilepsy syndrome	0.000191	0.00108	CcSEcCtD
Albendazole—Headache—Clonazepam—epilepsy syndrome	0.00019	0.00108	CcSEcCtD
Albendazole—Rash—Phenytoin—epilepsy syndrome	0.00019	0.00108	CcSEcCtD
Albendazole—Dermatitis—Phenytoin—epilepsy syndrome	0.00019	0.00108	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.00019	0.00108	CcSEcCtD
Albendazole—Rash—Oxcarbazepine—epilepsy syndrome	0.000189	0.00107	CcSEcCtD
Albendazole—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000189	0.00107	CcSEcCtD
Albendazole—Headache—Phenytoin—epilepsy syndrome	0.000189	0.00107	CcSEcCtD
Albendazole—Headache—Oxcarbazepine—epilepsy syndrome	0.000188	0.00107	CcSEcCtD
Albendazole—Nausea—Zonisamide—epilepsy syndrome	0.000187	0.00106	CcSEcCtD
Albendazole—ABCB1—nervous system—epilepsy syndrome	0.000185	0.00457	CbGeAlD
Albendazole—Dizziness—Lamotrigine—epilepsy syndrome	0.000184	0.00104	CcSEcCtD
Albendazole—Vomiting—Carbamazepine—epilepsy syndrome	0.000183	0.00104	CcSEcCtD
Albendazole—Rash—Carbamazepine—epilepsy syndrome	0.000182	0.00103	CcSEcCtD
Albendazole—Dermatitis—Carbamazepine—epilepsy syndrome	0.000182	0.00103	CcSEcCtD
Albendazole—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000181	0.00103	CcSEcCtD
Albendazole—Nausea—Clonazepam—epilepsy syndrome	0.000181	0.00102	CcSEcCtD
Albendazole—Headache—Carbamazepine—epilepsy syndrome	0.000181	0.00102	CcSEcCtD
Albendazole—Thrombocytopenia—Gabapentin—epilepsy syndrome	0.00018	0.00102	CcSEcCtD
Albendazole—Nausea—Phenytoin—epilepsy syndrome	0.000179	0.00102	CcSEcCtD
Albendazole—ABCB1—central nervous system—epilepsy syndrome	0.000179	0.0044	CbGeAlD
Albendazole—Nausea—Oxcarbazepine—epilepsy syndrome	0.000178	0.00101	CcSEcCtD
Albendazole—Skin disorder—Gabapentin—epilepsy syndrome	0.000178	0.00101	CcSEcCtD
Albendazole—Vomiting—Lamotrigine—epilepsy syndrome	0.000177	0.001	CcSEcCtD
Albendazole—Urticaria—Valproic Acid—epilepsy syndrome	0.000176	0.000997	CcSEcCtD
Albendazole—Rash—Lamotrigine—epilepsy syndrome	0.000176	0.000996	CcSEcCtD
Albendazole—Dermatitis—Lamotrigine—epilepsy syndrome	0.000175	0.000995	CcSEcCtD
Albendazole—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000175	0.000992	CcSEcCtD
Albendazole—Body temperature increased—Valproic Acid—epilepsy syndrome	0.000175	0.000992	CcSEcCtD
Albendazole—ABCB1—cerebellum—epilepsy syndrome	0.000174	0.0043	CbGeAlD
Albendazole—Headache—Lamotrigine—epilepsy syndrome	0.000174	0.000989	CcSEcCtD
Albendazole—Nausea—Carbamazepine—epilepsy syndrome	0.000171	0.00097	CcSEcCtD
Albendazole—Vertigo—Topiramate—epilepsy syndrome	0.00017	0.000963	CcSEcCtD
Albendazole—Leukopenia—Topiramate—epilepsy syndrome	0.000169	0.00096	CcSEcCtD
Albendazole—Nausea—Lamotrigine—epilepsy syndrome	0.000165	0.000938	CcSEcCtD
Albendazole—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000164	0.000928	CcSEcCtD
Albendazole—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000163	0.000924	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	0.00016	0.000907	CcSEcCtD
Albendazole—Urticaria—Pregabalin—epilepsy syndrome	0.000159	0.000901	CcSEcCtD
Albendazole—Abdominal pain—Pregabalin—epilepsy syndrome	0.000158	0.000897	CcSEcCtD
Albendazole—Body temperature increased—Pregabalin—epilepsy syndrome	0.000158	0.000897	CcSEcCtD
Albendazole—Thrombocytopenia—Topiramate—epilepsy syndrome	0.000151	0.000857	CcSEcCtD
Albendazole—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.00015	0.000851	CcSEcCtD
Albendazole—Skin disorder—Topiramate—epilepsy syndrome	0.00015	0.00085	CcSEcCtD
Albendazole—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000147	0.000836	CcSEcCtD
Albendazole—Dizziness—Valproic Acid—epilepsy syndrome	0.000146	0.00083	CcSEcCtD
Albendazole—Urticaria—Gabapentin—epilepsy syndrome	0.000146	0.000826	CcSEcCtD
Albendazole—Body temperature increased—Gabapentin—epilepsy syndrome	0.000145	0.000822	CcSEcCtD
Albendazole—Abdominal pain—Gabapentin—epilepsy syndrome	0.000145	0.000822	CcSEcCtD
Albendazole—ABCB1—brain—epilepsy syndrome	0.000142	0.00349	CbGeAlD
Albendazole—Vomiting—Valproic Acid—epilepsy syndrome	0.000141	0.000798	CcSEcCtD
Albendazole—Rash—Valproic Acid—epilepsy syndrome	0.00014	0.000791	CcSEcCtD
Albendazole—Dermatitis—Valproic Acid—epilepsy syndrome	0.000139	0.00079	CcSEcCtD
Albendazole—Headache—Valproic Acid—epilepsy syndrome	0.000139	0.000786	CcSEcCtD
Albendazole—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000135	0.000766	CcSEcCtD
Albendazole—Dizziness—Pregabalin—epilepsy syndrome	0.000132	0.00075	CcSEcCtD
Albendazole—Nausea—Valproic Acid—epilepsy syndrome	0.000131	0.000745	CcSEcCtD
Albendazole—Vomiting—Pregabalin—epilepsy syndrome	0.000127	0.000721	CcSEcCtD
Albendazole—Gastrointestinal pain—Topiramate—epilepsy syndrome	0.000126	0.000716	CcSEcCtD
Albendazole—Rash—Pregabalin—epilepsy syndrome	0.000126	0.000715	CcSEcCtD
Albendazole—Dermatitis—Pregabalin—epilepsy syndrome	0.000126	0.000715	CcSEcCtD
Albendazole—Headache—Pregabalin—epilepsy syndrome	0.000125	0.000711	CcSEcCtD
Albendazole—Urticaria—Topiramate—epilepsy syndrome	0.000123	0.000695	CcSEcCtD
Albendazole—Body temperature increased—Topiramate—epilepsy syndrome	0.000122	0.000692	CcSEcCtD
Albendazole—Abdominal pain—Topiramate—epilepsy syndrome	0.000122	0.000692	CcSEcCtD
Albendazole—Dizziness—Gabapentin—epilepsy syndrome	0.000121	0.000688	CcSEcCtD
Albendazole—Nausea—Pregabalin—epilepsy syndrome	0.000119	0.000674	CcSEcCtD
Albendazole—Vomiting—Gabapentin—epilepsy syndrome	0.000117	0.000661	CcSEcCtD
Albendazole—Rash—Gabapentin—epilepsy syndrome	0.000116	0.000656	CcSEcCtD
Albendazole—Dermatitis—Gabapentin—epilepsy syndrome	0.000116	0.000655	CcSEcCtD
Albendazole—Headache—Gabapentin—epilepsy syndrome	0.000115	0.000652	CcSEcCtD
Albendazole—Hypersensitivity—Topiramate—epilepsy syndrome	0.000114	0.000645	CcSEcCtD
Albendazole—Nausea—Gabapentin—epilepsy syndrome	0.000109	0.000618	CcSEcCtD
Albendazole—Dizziness—Topiramate—epilepsy syndrome	0.000102	0.000579	CcSEcCtD
Albendazole—Vomiting—Topiramate—epilepsy syndrome	9.81e-05	0.000556	CcSEcCtD
Albendazole—Rash—Topiramate—epilepsy syndrome	9.73e-05	0.000552	CcSEcCtD
Albendazole—Dermatitis—Topiramate—epilepsy syndrome	9.72e-05	0.000551	CcSEcCtD
Albendazole—Headache—Topiramate—epilepsy syndrome	9.67e-05	0.000548	CcSEcCtD
Albendazole—Nausea—Topiramate—epilepsy syndrome	9.17e-05	0.00052	CcSEcCtD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	2.34e-05	0.000358	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	2.33e-05	0.000357	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—EPM2A—epilepsy syndrome	2.32e-05	0.000356	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—NHLRC1—epilepsy syndrome	2.32e-05	0.000356	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PNPO—epilepsy syndrome	2.32e-05	0.000356	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GAMT—epilepsy syndrome	2.32e-05	0.000356	CbGpPWpGaD
Albendazole—TUBB4B—Metabolism of proteins—CCL2—epilepsy syndrome	2.3e-05	0.000352	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	2.25e-05	0.000345	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	2.25e-05	0.000345	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	2.22e-05	0.00034	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—UPB1—epilepsy syndrome	2.2e-05	0.000338	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—NEU1—epilepsy syndrome	2.2e-05	0.000338	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ATIC—epilepsy syndrome	2.2e-05	0.000338	CbGpPWpGaD
Albendazole—ABCB1—Allograft Rejection—TNF—epilepsy syndrome	2.16e-05	0.000331	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CA4—epilepsy syndrome	2.16e-05	0.000331	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—QDPR—epilepsy syndrome	2.16e-05	0.000331	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	2.16e-05	0.000331	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	2.15e-05	0.00033	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—HSD17B4—epilepsy syndrome	2.12e-05	0.000325	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CA13—epilepsy syndrome	2.06e-05	0.000316	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GBE1—epilepsy syndrome	2.05e-05	0.000314	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PPP1R3C—epilepsy syndrome	2.05e-05	0.000314	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—COX3—epilepsy syndrome	2.03e-05	0.000311	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—FAR1—epilepsy syndrome	2.03e-05	0.00031	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GLUD1—epilepsy syndrome	2.03e-05	0.00031	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ADK—epilepsy syndrome	2.03e-05	0.00031	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PDXK—epilepsy syndrome	2.03e-05	0.00031	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CERS1—epilepsy syndrome	2.03e-05	0.00031	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—L2HGDH—epilepsy syndrome	2.03e-05	0.00031	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	2.01e-05	0.000307	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	2e-05	0.000307	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	1.94e-05	0.000297	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ASAH1—epilepsy syndrome	1.93e-05	0.000295	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CACNA2D2—epilepsy syndrome	1.92e-05	0.000295	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—KCNB1—epilepsy syndrome	1.92e-05	0.000295	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PFKL—epilepsy syndrome	1.92e-05	0.000295	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—SLCO1A2—epilepsy syndrome	1.92e-05	0.000295	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—SLC6A8—epilepsy syndrome	1.92e-05	0.000295	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—STXBP1—epilepsy syndrome	1.87e-05	0.000287	CbGpPWpGaD
Albendazole—ABCB1—HIF-1-alpha transcription factor network—AKT1—epilepsy syndrome	1.86e-05	0.000284	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GAMT—epilepsy syndrome	1.85e-05	0.000284	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—NHLRC1—epilepsy syndrome	1.85e-05	0.000284	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—EPM2A—epilepsy syndrome	1.85e-05	0.000284	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PNPO—epilepsy syndrome	1.85e-05	0.000284	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	1.83e-05	0.000281	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—NT5E—epilepsy syndrome	1.83e-05	0.00028	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ALAD—epilepsy syndrome	1.83e-05	0.00028	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	1.79e-05	0.000274	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ATIC—epilepsy syndrome	1.76e-05	0.00027	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—UPB1—epilepsy syndrome	1.76e-05	0.00027	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—NEU1—epilepsy syndrome	1.76e-05	0.00027	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	1.75e-05	0.000268	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CACNA1A—epilepsy syndrome	1.74e-05	0.000267	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ALDH7A1—epilepsy syndrome	1.74e-05	0.000267	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CA4—epilepsy syndrome	1.72e-05	0.000264	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—QDPR—epilepsy syndrome	1.72e-05	0.000264	CbGpPWpGaD
Albendazole—CYP1A2—Biological oxidations—POMC—epilepsy syndrome	1.72e-05	0.000263	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ST3GAL3—epilepsy syndrome	1.7e-05	0.000261	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—HSD17B4—epilepsy syndrome	1.69e-05	0.00026	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ADSL—epilepsy syndrome	1.67e-05	0.000256	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	1.66e-05	0.000255	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GLUL—epilepsy syndrome	1.64e-05	0.000251	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GBE1—epilepsy syndrome	1.64e-05	0.000251	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PPP1R3C—epilepsy syndrome	1.64e-05	0.000251	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—COX3—epilepsy syndrome	1.62e-05	0.000248	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CACNA1D—epilepsy syndrome	1.61e-05	0.000246	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	1.58e-05	0.000242	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CERS1—epilepsy syndrome	1.56e-05	0.00024	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	1.56e-05	0.00024	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PDXK—epilepsy syndrome	1.56e-05	0.00024	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ADK—epilepsy syndrome	1.56e-05	0.00024	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	1.56e-05	0.00024	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—FAR1—epilepsy syndrome	1.56e-05	0.00024	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ASAH1—epilepsy syndrome	1.54e-05	0.000236	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PFKL—epilepsy syndrome	1.54e-05	0.000235	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—KCNB1—epilepsy syndrome	1.54e-05	0.000235	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SLCO1A2—epilepsy syndrome	1.54e-05	0.000235	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CACNA2D2—epilepsy syndrome	1.54e-05	0.000235	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SLC6A8—epilepsy syndrome	1.54e-05	0.000235	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1.52e-05	0.000233	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—TXNRD1—epilepsy syndrome	1.5e-05	0.00023	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.5e-05	0.00023	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—STXBP1—epilepsy syndrome	1.5e-05	0.000229	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.49e-05	0.000229	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	1.47e-05	0.000224	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—AQP1—epilepsy syndrome	1.46e-05	0.000224	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—NT5E—epilepsy syndrome	1.46e-05	0.000223	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ALAD—epilepsy syndrome	1.46e-05	0.000223	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.45e-05	0.000222	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	1.43e-05	0.000219	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PNPO—epilepsy syndrome	1.43e-05	0.000219	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	1.43e-05	0.000219	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GAMT—epilepsy syndrome	1.43e-05	0.000219	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	1.42e-05	0.000218	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ATIC—epilepsy syndrome	1.4e-05	0.000215	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—UPB1—epilepsy syndrome	1.4e-05	0.000215	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—NEU1—epilepsy syndrome	1.4e-05	0.000215	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.4e-05	0.000215	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	1.39e-05	0.000213	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	1.39e-05	0.000213	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	1.36e-05	0.000209	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—HSD17B4—epilepsy syndrome	1.35e-05	0.000207	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ADSL—epilepsy syndrome	1.33e-05	0.000204	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—QDPR—epilepsy syndrome	1.33e-05	0.000204	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CA4—epilepsy syndrome	1.33e-05	0.000204	CbGpPWpGaD
Albendazole—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	1.33e-05	0.000203	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—KCNJ11—epilepsy syndrome	1.32e-05	0.000202	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CHRM3—epilepsy syndrome	1.32e-05	0.000202	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GLUL—epilepsy syndrome	1.31e-05	0.0002	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GBE1—epilepsy syndrome	1.31e-05	0.0002	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	1.31e-05	0.0002	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	1.28e-05	0.000197	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	1.28e-05	0.000196	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.28e-05	0.000196	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—COX3—epilepsy syndrome	1.25e-05	0.000192	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	1.24e-05	0.00019	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.23e-05	0.000188	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	1.23e-05	0.000188	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.2e-05	0.000184	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	1.2e-05	0.000184	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	1.19e-05	0.000183	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.19e-05	0.000183	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.19e-05	0.000182	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.19e-05	0.000182	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.19e-05	0.000182	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.19e-05	0.000182	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.19e-05	0.000182	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.18e-05	0.000181	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—AQP1—epilepsy syndrome	1.17e-05	0.000179	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—NT5E—epilepsy syndrome	1.16e-05	0.000178	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ALAD—epilepsy syndrome	1.16e-05	0.000178	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	1.11e-05	0.00017	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	1.11e-05	0.00017	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	1.09e-05	0.000166	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—NEU1—epilepsy syndrome	1.08e-05	0.000166	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—UPB1—epilepsy syndrome	1.08e-05	0.000166	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ATIC—epilepsy syndrome	1.08e-05	0.000166	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ABCG2—epilepsy syndrome	1.08e-05	0.000165	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	1.07e-05	0.000163	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ADSL—epilepsy syndrome	1.06e-05	0.000163	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CHRM3—epilepsy syndrome	1.05e-05	0.000162	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	1.05e-05	0.000162	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CYP2C19—epilepsy syndrome	1.05e-05	0.000161	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GLUL—epilepsy syndrome	1.04e-05	0.00016	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	1.04e-05	0.00016	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CYP11A1—epilepsy syndrome	1.04e-05	0.00016	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.03e-05	0.000158	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	1.02e-05	0.000157	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	1.01e-05	0.000154	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GBE1—epilepsy syndrome	1.01e-05	0.000154	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	9.58e-06	0.000147	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	9.48e-06	0.000145	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	9.43e-06	0.000145	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CYP2D6—epilepsy syndrome	9.4e-06	0.000144	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—AQP1—epilepsy syndrome	9.3e-06	0.000143	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	9.22e-06	0.000141	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—NT5E—epilepsy syndrome	8.98e-06	0.000138	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ALAD—epilepsy syndrome	8.98e-06	0.000138	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ADRA2A—epilepsy syndrome	8.95e-06	0.000137	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	8.94e-06	0.000137	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—BCHE—epilepsy syndrome	8.91e-06	0.000137	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ABCG2—epilepsy syndrome	8.59e-06	0.000132	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	8.57e-06	0.000131	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	8.57e-06	0.000131	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—SLC2A1—epilepsy syndrome	8.5e-06	0.00013	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	8.41e-06	0.000129	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	8.41e-06	0.000129	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PLCB1—epilepsy syndrome	8.41e-06	0.000129	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	8.39e-06	0.000128	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—TH—epilepsy syndrome	8.38e-06	0.000128	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	8.37e-06	0.000128	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	8.32e-06	0.000128	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	8.25e-06	0.000126	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ADSL—epilepsy syndrome	8.22e-06	0.000126	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GLUL—epilepsy syndrome	8.06e-06	0.000123	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	7.93e-06	0.000122	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	7.91e-06	0.000121	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	7.84e-06	0.00012	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	7.68e-06	0.000118	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	7.51e-06	0.000115	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	7.4e-06	0.000113	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—AQP1—epilepsy syndrome	7.18e-06	0.00011	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	7.16e-06	0.00011	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	7.15e-06	0.00011	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—BCHE—epilepsy syndrome	7.12e-06	0.000109	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—HMOX1—epilepsy syndrome	7e-06	0.000107	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CAT—epilepsy syndrome	6.9e-06	0.000106	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	6.86e-06	0.000105	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	6.79e-06	0.000104	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PLCB1—epilepsy syndrome	6.72e-06	0.000103	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ABCB1—epilepsy syndrome	6.71e-06	0.000103	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—TH—epilepsy syndrome	6.69e-06	0.000103	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	6.69e-06	0.000102	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	6.64e-06	0.000102	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	6.6e-06	0.000101	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	6.49e-06	9.95e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	6.49e-06	9.95e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GPX1—epilepsy syndrome	6.24e-06	9.56e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	6.01e-06	9.21e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	6e-06	9.19e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	5.71e-06	8.75e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—BCHE—epilepsy syndrome	5.68e-06	8.71e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—HMOX1—epilepsy syndrome	5.59e-06	8.56e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CAT—epilepsy syndrome	5.51e-06	8.45e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—AGT—epilepsy syndrome	5.47e-06	8.39e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	5.42e-06	8.31e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	5.36e-06	8.22e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—APOE—epilepsy syndrome	5.36e-06	8.22e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—TH—epilepsy syndrome	5.34e-06	8.19e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	5.29e-06	8.11e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	5.26e-06	8.06e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	5.16e-06	7.9e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	5.13e-06	7.86e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GPX1—epilepsy syndrome	4.99e-06	7.64e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	4.63e-06	7.09e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—POMC—epilepsy syndrome	4.61e-06	7.06e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	4.46e-06	6.83e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	4.41e-06	6.75e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CAT—epilepsy syndrome	4.4e-06	6.74e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—BCHE—epilepsy syndrome	4.39e-06	6.72e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—AGT—epilepsy syndrome	4.37e-06	6.7e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—APOE—epilepsy syndrome	4.28e-06	6.56e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	4.28e-06	6.56e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ALB—epilepsy syndrome	4.2e-06	6.44e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	4.18e-06	6.41e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	4.14e-06	6.34e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—TH—epilepsy syndrome	4.12e-06	6.32e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GPX1—epilepsy syndrome	3.98e-06	6.1e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—POMC—epilepsy syndrome	3.68e-06	5.64e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PTGS2—epilepsy syndrome	3.67e-06	5.63e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—AGT—epilepsy syndrome	3.49e-06	5.35e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	3.44e-06	5.27e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—APOE—epilepsy syndrome	3.42e-06	5.24e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CAT—epilepsy syndrome	3.4e-06	5.2e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ALB—epilepsy syndrome	3.35e-06	5.14e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	3.3e-06	5.06e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GPX1—epilepsy syndrome	3.07e-06	4.71e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—POMC—epilepsy syndrome	2.94e-06	4.5e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PTGS2—epilepsy syndrome	2.94e-06	4.5e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—AGT—epilepsy syndrome	2.69e-06	4.13e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ALB—epilepsy syndrome	2.68e-06	4.1e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—APOE—epilepsy syndrome	2.64e-06	4.04e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	2.34e-06	3.59e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—POMC—epilepsy syndrome	2.27e-06	3.47e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ALB—epilepsy syndrome	2.07e-06	3.17e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—AKT1—epilepsy syndrome	1.85e-06	2.83e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.81e-06	2.77e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—AKT1—epilepsy syndrome	1.48e-06	2.26e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—AKT1—epilepsy syndrome	1.18e-06	1.8e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—AKT1—epilepsy syndrome	9.09e-07	1.39e-05	CbGpPWpGaD
